))
3 Hidden Dangers of Telehealth Marketing
Manage episode 431339865 series 3506216
İçerik Darshan Kulkarni tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Darshan Kulkarni veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
In this episode, we discuss how drug and device manufacturers may seem to collaborate with telemedicine companies to market products and ensure patient needs are met conveniently. However, there are three major concerns:
1. Ignoring Pharma Laws: Telehealth companies might not adhere to pharma marketing laws and could act as agents for pharma due to developed relationships. This has drawn scrutiny from Congress, FDA, and FTC, raising concerns about potential non-compliance.
2. Inappropriate Product Sales: There are significant concerns about how telehealth and marketing companies are identifying patients. Inappropriate sales to patients who don't need the products have led to Department of Justice inquiries.
3. Signing Unnecessary prescriptions: Some telehealth companies use doctors to sign off on prescriptions for patients who may not need them, often influenced by kickbacks. This practice is highly problematic and may deter pharma companies from associations unless proper controls are in place.
For assistance with advertising compliance, reach out to us!
108 bölüm
Paylaş
